Pages that link to "Q53958238"

The following pages link to Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. (Q53958238):

Displaying 36 items.

• Neuroendocrine differentiation in prostate cancer (Q24657547) (← links)
• T-type calcium channels blockers as new tools in cancer therapies (Q28306311) (← links)
• Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression (Q30432236) (← links)
• Neuroendocrine Cells of the Prostate Derive from the Neural Crest. (Q30837415) (← links)
• TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival (Q34218298) (← links)
• Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells. (Q34438254) (← links)
• Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma (Q34478021) (← links)
• Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. (Q34545497) (← links)
• Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma. (Q34689297) (← links)
• Models of metastatic prostate cancer: a transgenic perspective (Q35217386) (← links)
• EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt (Q35945055) (← links)
• Neuroendocrine differentiation in prostate cancer (Q36537698) (← links)
• Molecular markers of prostate cancer (Q36669988) (← links)
• Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies (Q36796375) (← links)
• Ion channels in death and differentiation of prostate cancer cells. (Q36811138) (← links)
• Ion channels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. (Q37937313) (← links)
• What is the pathophysiology of a hormone-resistant prostate tumour? (Q37937865) (← links)
• Biology of castration-recurrent prostate cancer (Q38053667) (← links)
• Prognostic significance of focal neuroendocrine differentiation in prostate cancer: cases with autopsy-verified cause of death (Q38416151) (← links)
• Factors implicated in radiation therapy failure and radiosensitization of prostate cancer (Q38807901) (← links)
• Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells. (Q39455141) (← links)
• Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications (Q39733396) (← links)
• Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells (Q40605826) (← links)
• Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. (Q40645346) (← links)
• The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates (Q41118422) (← links)
• Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer (Q41886996) (← links)
• Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells (Q42382543) (← links)
• Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype (Q44817262) (← links)
• Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study (Q46648562) (← links)
• MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells. (Q52714356) (← links)
• Chromogranin A staining as a prognostic variable in newly diagnosed Gleason score 7-10 prostate cancer treated with definitive radiotherapy. (Q54388747) (← links)
• A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor. (Q55285562) (← links)
• Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma (Q80826843) (← links)
• [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype] (Q81288149) (← links)
• [Infiltrating mast cells promote neuroendocrine differentiation and increase docetaxel resistance of prostate cancer cells by up-regulating p21] (Q89573875) (← links)
• ECTOPIC ADRENOCORTICOTROPIC HORMONE SYNDROME DUE TO METASTATIC PROSTATE CANCER WITH NEUROENDOCRINE DIFFERENTIATION (Q92842085) (← links)